| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 865149-76-4 | 6-Chloro-2-(difluoromethoxy)aniline;2-Chloro-6-(difluoromethoxy)benzenamine | C7H6ClF2NO |
| 865156-48-5 | 7-Bromoimidazo(1,5-a)pyridine | C7H5BrN2 |
| 865156-50-9 | 4-Bromo-2-pyridinemethanamine | C6H7BrN2 |
| 865156-68-9 | 6-Bromoimidazo(1,2-a)pyrimidine | C6H4BrN3 |
| 865156-81-6 | 6-Bromo-1-(3-methoxypropyl)-3-methyl-1H-indazole | C12H15BrN2O |
| 865157-02-4 | (R)-3-((Methoxycarbonyl)methyl)piperidine-1-carboxylic acid tert-butyl ester | C13H23NO4 |
| 865157-03-5 | Methyl (R)-piperidine-3-acetate hydrochloride;(3R)-3-Piperidineacetic acid, methyl ester, hydrochloride | C8H15NO2.HCl |
| 865186-94-3 | 5-Chloropyridine-3-boronic acid pinacol ester | C11H15BClNO2 |
| 865231-46-5 | (betaS)-beta-1-Propyn-1-yl-4-((4'-(trifluoromethyl)(1,1'-biphenyl)-3-yl)methoxy)benzenepropanoic acid;AMG 837 | C26H21F3O3 |
| 865233-35-8 | (3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid | C12H12O3 |
| 865245-32-5 | N-Boc-3,4-Dihydropyridine-6-boronic acid pinacol ester;3,4-Dihydro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1(2H)-pyridinecarboxylic acid tert butyl ester | C16H28BNO4 |
| 865305-30-2 | 5-(5-Iodo-4-methoxy-2-(1-methylethyl)phenoxy)-2,4-pyrimidinediamine;AF 353; Ro 4 | C14H17IN4O2 |
| 865311-47-3 | CX 3543;Quarfloxacin; Itarnafloxin; 5-Fluoro-N-(2-((2S)-1-methyl-2-pyrrolidinyl)ethyl)-3-oxo-6-(3-(2-pyrazinyl)-1-pyrrolidinyl)-3H-benzo(b)pyrido(3,2,1-kl)phenoxazine-2-carboxamide | C35H33FN6O3 |
| 865350-17-0 | 4,4,5,5-Tetramethyl-2-propadienyl-1,3,2-dioxaborolane | C9H15BO2 |
| 865352-01-8 | 2-(2,2-Difluoroethoxy)-6-(trifluoromethyl)benzene-1-sulfonyl chloride | C9H6ClF5O3S |
| 865352-21-2 | (2R)-2-(((9H-Fluoren-9-ylmethoxy)carbonyl)amino)-5-hexenoic acid | C21H21NO4 |
| 865362-74-9 | 5-(2-Phenylpyrazolo(1,5-a)pyridin-3-yl)-1H-pyrazolo(3,4-c)pyridazin-3-amine;FR 180204 | C18H13N7 |
| 865363-93-5 | 2'-Deoxy-4'-C-ethynyl-2-fluoroadenosine | C12H12FN5O3 |
| 865435-18-3 | 2,9,10-Tris(2-naphthyl)anthracene | C44H28 |
| 865435-20-7 | 9,10-Bis(2-naphthyl)-2-phenylanthracene;9,10-Di(naphthalen-2-yl)-2-phenylanthracene; 9,10-Di-2-naphthyl-2-phenylanthracene | C40H26 |
| 865448-72-2 | N,N,N',N'-Tetra(4-formylphenyl)-1,1'-biphenyl-4,4'-diamine | C40H28N2O4 |
| 865449-16-7 | 3-Bromo-4-(dibromomethyl)pyridine | C6H4Br3N |
| 865449-63-4 | 1-(4-Bromo-5-fluoro-2-hydroxyphenyl)ethanone | C8H6BrFO2 |
| 865449-97-4 | 1,3-Benzoxazole-6-carbaldehyde | C8H5NO2 |
| 865450-09-5 | 2-Methyl-2-propanyl (2-fluoro-4-formylphenyl)carbamate | C12H14FNO3 |
| 865451-85-0 | 3-Fluoro-3-(hydroxymethyl)oxetane;(3-Fluorooxetan-3-yl)methanol | C4H7FO2 |
| 865466-24-6 | Sch 900518;Narlaprevir; (1R,2S,5S)-N-((1S)-1-((Cyclopropylamino)oxoacetyl)pentyl)-3-((2S)-2-((((1-(((1,1-dimethylethyl)sulfonyl)methyl)cyclohexyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexane-2-carboxamide | C36H61N5O7S |
| 865470-86-6 | 5-[(4-Methyl-1-piperazinyl)methyl]-2-furoic acid | C11H16N2O3 |
| 865471-20-1 | 2-(4-Morpholinyl)-5-(trifluoromethyl)benzoic acid | C12H12F3NO3 |
| 865472-04-4 | 7-Bromo-1,2,3,4-Tetrahydro-1-Naphthalenamine | C10H12BrN |
| 865479-71-6 | 5-R-Rivaroxaban;5-Chloro-N-(((5R)-2-oxo-3-(4-(3-oxo-4-morpholinyl)phenyl)-5-oxazolidinyl)methyl)-2-thiophenecarboxamide | C19H18ClN3O5S |
| 865485-85-4 | 4,4,5,5-Tetramethyl-2-(4-((1,2,2-trifluoroethenyl)oxy)phenyl)-1,3,2-dioxaborolane | C14H16BF3O3 |
| 865536-65-8 | 3-Keto fenretinide;4-Oxofenretinide; 4-Oxo-N-(4-hydroxyphenyl)retinamide | C26H31NO3 |
| 865546-36-7 | 1-(3-Pyridinyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine | C12H13N3 |
| 865604-20-2 | 3,4'-Bipyridin-2'-amine | C10H9N3 |
| 865624-17-5 | 1-(Bromomethyl)-3-chloro-5-nitrobenzene;5-Chloro-3-nitrobenzyl bromide | C7H5BrClNO2 |
| 865663-96-3 | 2-Chloro-3-(difluoromethyl)pyridine | C6H4ClF2N |
| 865689-24-3 | (1R,6R)-6-({[(2-Methyl-2-propanyl)oxy]carbonyl}amino)-3-cyclohexene-1-carboxylic acid | C12H19NO4 |
| 865718-75-8 | (2-bromo-4-methyl-phenyl)methanamine | C8H10BrN |
| 865758-37-8 | 1-{Chloro[4-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)phenyl]phenylmethyl}-4-methoxybenzene | C30H20ClF17O |
| 865758-95-8 | 2-((6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)methyl)benzonitrile | C12H8ClN3O2 |
| 865758-96-9 | 2-((6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl)benzonitrile | C13H10ClN3O2 |
| 865758-98-1 | Alogliptin Impurity 17;Alogliptin metabolite M-I; 2-((6-((3R)-3-aminopiperidin-1-yl)-2,4-dioxopyrimidin-1-yl)methyl)benzonitrile | C17H19N5O2 |
| 865759-10-0 | Alogliptin Impurity 26;2-((6-(3-aminopiperidin-1-yl)-3-((2-cyanophenyl)methyl)-2,4-dioxopyrimidin-1-yl)methyl)benzonitrile | C25H24N6O2 |
| 865759-24-6 | 2-((6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl)-4-fluorobenzonitrile | C13H9ClFN3O2 |
| 865759-25-7 | Trelagliptin;(R)-2-((6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile | C18H20FN5O2 |
| 865773-15-5 | (2S)-2-((6,8-Difluoro-1,2,3,4-tetrahydro-2-naphthalenyl)amino)-N-(1-(2-((2,2-dimethylpropyl)amino)-1,1-dimethylethyl)-1H-imidazol-4-yl)pentanamide | C27H41F2N5O |
| 865774-07-8 | methyl 2-methyl-2-(4-nitro-1H-imidazol-1-yl)propanoate | C8H11N3O4 |
| 865774-79-4 | N-((2S)-6,8-difluoro-1,2,3,4-tetrahydro-2-naphthalenyl)-L-Norvaline | C15H19F2NO2 |
| 865783-99-9 | Briciclib;(E)-5-(((2,4,6-Trimethoxystyryl)sulfonyl)methyl)-2-methoxyphenyl dihydrogen phosphate; ON 014185 | C19H23O10PS |